Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol Article

cited authors

  • Weng, Liming; Gong, Yan; Culver, Jeffrey; Gardell, Stephen J.; Petucci, Christopher; Morse, Alison M.; Frye, Reginald F.; Turner, Stephen T.; Chapman, Arlene; Boerwinkle, Eric; Gums, John; Beitelshees, Amber L.; Borum, Peggy R.; Johnson, Julie A.; Garrett, Timothy J.; McIntyre, Lauren M.; Cooper-DeHoff, Rhonda M.

authors

Publication Date

  • October 1, 2016

webpage

published in

category

keywords

  • Acylcarnitine
  • Arachidonoyl-carnitine
  • Atenolol
  • C20:4
  • Cardiometabolic syndrome
  • Hypertension
  • Pharmacometabolomics

volume

  • 12

issue

  • 10